#1 Clinical Trials Search in Europe

Noradrenaline Tartrate

Noradrenaline Tartrate, also known as norepinephrine, is a powerful vasopressor medication being studied in various clinical trials for its potential benefits in critical care and surgical settings. These trials aim to evaluate its effectiveness in managing blood pressure, improving organ perfusion, and potentially reducing complications in conditions such as cardiogenic shock, acute kidney injury, and progressive stroke. This article summarizes key findings from recent clinical trials investigating the use of Noradrenaline Tartrate in different medical scenarios.

Table of Contents

What is Noradrenaline Tartrate?

Noradrenaline Tartrate, also known as Norepinephrine Bitartrate, is a medication used to treat various medical conditions, primarily those involving low blood pressure[1]. It is a synthetic version of norepinephrine, a naturally occurring hormone and neurotransmitter in the body. Noradrenaline plays a crucial role in the body’s “fight or flight” response and helps regulate blood pressure, heart rate, and blood flow to vital organs.

Medical Uses

Noradrenaline Tartrate is primarily used in critical care settings to treat conditions such as:

  • Shock: It is used to treat various types of shock, including cardiogenic shock (resulting from heart problems) and vasoplegic syndrome (a type of shock that can occur after cardiac surgery)[1].
  • Hypotension: It helps raise blood pressure in patients with dangerously low blood pressure[2].
  • Cardiac Arrest: It may be used as part of the treatment protocol for cardiac arrest[3].
  • Organ Support: In critical situations, it helps maintain blood flow to vital organs[4].

How is it Administered?

Noradrenaline Tartrate is typically administered intravenously (through a vein) in a hospital setting, usually in an intensive care unit (ICU) or during surgery. It is given as a continuous infusion, with the dose carefully adjusted based on the patient’s response and blood pressure readings[5]. The medication is diluted in a solution before administration to ensure proper dosing and to minimize the risk of side effects.

Potential Side Effects

While Noradrenaline Tartrate is a life-saving medication, it can cause side effects, especially if not administered correctly. Some potential side effects include:

  • Hypertension: Excessively high blood pressure
  • Arrhythmias: Irregular heart rhythms
  • Tissue Ischemia: Reduced blood flow to certain tissues, particularly in the extremities
  • Anxiety: Feelings of nervousness or restlessness
  • Headache
  • Nausea

Healthcare providers closely monitor patients receiving Noradrenaline Tartrate to minimize these risks and adjust the dosage as needed[6].

Precautions and Contraindications

Noradrenaline Tartrate should be used with caution in certain situations:

  • Pregnancy: It should only be used if the potential benefit justifies the potential risk to the fetus[1].
  • Heart Conditions: Patients with certain heart conditions may be at higher risk of complications.
  • Interactions: It can interact with certain medications, including some antidepressants and anesthetics.

The medication is contraindicated in patients with known hypersensitivity to noradrenaline or any of its components[4].

Current Research

Ongoing research is exploring new applications and optimizing the use of Noradrenaline Tartrate:

  • Vasoplegic Syndrome: A study is comparing the effectiveness of vasopressin versus noradrenaline in managing patients with vasoplegic syndrome undergoing cardiac surgery[1].
  • Acute Kidney Injury: Research is investigating whether low-dose arginine-vasopressin supplementation with noradrenaline can reduce acute kidney injury after liver transplantation[4].
  • Stroke Treatment: A trial is exploring the use of noradrenaline to induce hypertension in patients with acute progressive stroke, aiming to improve outcomes[6].
  • Cardiogenic Shock: A study is examining whether a strategy of reduced noradrenaline use can improve outcomes in patients with cardiogenic shock following acute myocardial infarction[7].

These studies aim to refine the use of Noradrenaline Tartrate and potentially expand its applications in critical care medicine.

Trial Focus Key Objectives Patient Population Main Outcomes Measured
Vasoplegic syndrome in cardiac surgery Compare vasopressin vs norepinephrine for renal complications and death Patients undergoing cardiac surgery with extracorporeal circulation Renal complications, mortality, cardiac complications
Post-cardiac arrest shock Assess efficacy of high-dose vitamin C with norepinephrine Patients with out-of-hospital cardiac arrest and post-arrest shock Vasopressor need, mortality, neurological outcome
Tracheal intubation in critical illness Evaluate pre-emptive vasopressor therapy during intubation Critically ill adults undergoing urgent tracheal intubation Cardiovascular collapse, blood pressure changes
Liver transplantation Study effect of arginine-vasopressin on post-transplant acute kidney injury Adult patients undergoing liver transplantation Acute kidney injury, need for renal replacement therapy
Acute progressive stroke Assess induced hypertension using norepinephrine in progressive stroke Patients with acute progressive perforating artery stroke Functional independence, neurological improvement
Cardiogenic shock in myocardial infarction Test reduced norepinephrine use with lower blood pressure target Patients with cardiogenic shock from acute myocardial infarction Mortality, renal failure, days alive out of hospital

FAQ

  • What is Noradrenaline Tartrate used for in clinical trials? Noradrenaline Tartrate is being studied in clinical trials for managing blood pressure in various critical care situations, including cardiogenic shock, post-cardiac arrest, liver transplantation, and acute progressive stroke. It's also being investigated for its potential to improve organ perfusion and reduce complications in these conditions.
  • How does Noradrenaline Tartrate work? Noradrenaline Tartrate is a vasopressor, which means it constricts blood vessels to increase blood pressure. This helps improve blood flow to vital organs in patients experiencing shock or other conditions where blood pressure is dangerously low.
  • Are there any side effects associated with Noradrenaline Tartrate use? Some potential side effects being monitored in clinical trials include hypertension (high blood pressure), tachyarrhythmia (rapid heart rate), acute coronary syndrome, and tissue injury if the drug extravasates (leaks out of the vein). The trials are carefully assessing the safety profile of Noradrenaline Tartrate in different patient populations.
  • How is Noradrenaline Tartrate administered in these trials? In most trials, Noradrenaline Tartrate is administered intravenously, often as a continuous infusion. The dosage and duration of treatment vary depending on the specific trial and the patient's condition. Some trials are comparing different dosing strategies or combining it with other treatments.
  • What are some key outcomes being measured in these Noradrenaline Tartrate trials? Key outcomes being measured include mortality rates, organ function (particularly kidney function), length of hospital stay, need for additional interventions, and long-term functional outcomes. Some trials are also looking at cost-effectiveness and quality of life measures. The specific outcomes vary depending on the focus of each trial.

Ongoing Clinical Trials on Noradrenaline Tartrate

  • Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study on Preventing Cardiovascular Collapse in Critically Ill Adults Using Noradrenaline Tartrate During Tracheal Intubation

    Recruiting

    3 1 1 1
    Investigated drugs:
    Ireland Italy

  • Study on the Effects of Phenylephrine and Noradrenaline on Blood Pressure and Brain Circulation in Patients with Low Blood Pressure During Brain Tumor Surgery

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark

  • Study on Norepinephrine for Improving Outcomes in Patients with Acute Progressive Stroke

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on Fluid Therapy and Noradrenaline for Low Blood Pressure in Breast Reconstruction Surgery Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium

  • Study on the Effect of Arginine-Vasopressin and Noradrenaline Tartrate on Acute Kidney Injury in Liver Transplant Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of dexmedetomidine and a drug combination for treating patients on mechanical ventilation with septic shock.

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Vasopressor: A type of medication that constricts (narrows) blood vessels and raises blood pressure.
  • Cardiogenic shock: A serious condition where the heart suddenly can't pump enough blood to meet the body's needs, often due to a severe heart attack.
  • Acute Kidney Injury (AKI): A sudden episode of kidney failure or kidney damage that happens within a few hours or days.
  • Vasoplegic syndrome: A condition characterized by low blood pressure due to extreme dilation of blood vessels, often occurring after heart surgery.
  • Extracorporeal circulation: A technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body.
  • Modified Rankin Scale (mRS): A scale used to measure the degree of disability in patients who have suffered a stroke or other neurological injuries.
  • National Institutes of Health Stroke Scale (NIHSS): A tool used to objectively quantify the impairment caused by a stroke.
  • Renal replacement therapy: A therapy that replaces the normal blood-filtering function of the kidneys, used when the kidneys are not working well.
  • STEMI: ST-Elevation Myocardial Infarction, a serious type of heart attack where a major heart artery is completely blocked.
  • NSTEMI: Non-ST-Elevation Myocardial Infarction, a type of heart attack where a coronary artery is partially blocked.

References

  1. http://clinicaltrials.eu/trial/study-comparing-vasopressin-and-noradrenaline-for-patients-with-vasoplegic-syndrome-undergoing-cardiac-surgery-with-extracorporeal-circulation/
  2. http://clinicaltrials.eu/trial/study-on-fluid-therapy-and-noradrenaline-for-low-blood-pressure-in-breast-reconstruction-surgery-patients/
  3. http://clinicaltrials.eu/trial/study-on-the-effectiveness-of-high-dose-vitamin-c-for-patients-with-shock-after-cardiac-arrest/
  4. http://clinicaltrials.eu/trial/study-on-the-effect-of-arginine-vasopressin-and-noradrenaline-tartrate-on-acute-kidney-injury-in-liver-transplant-patients/
  5. http://clinicaltrials.eu/trial/study-on-preventing-cardiovascular-collapse-in-critically-ill-adults-using-noradrenaline-tartrate-during-tracheal-intubation/
  6. http://clinicaltrials.eu/trial/study-on-norepinephrine-for-improving-outcomes-in-patients-with-acute-progressive-stroke/
  7. http://clinicaltrials.eu/trial/study-on-lowering-noradrenaline-use-for-patients-with-cardiogenic-shock-from-heart-attack/